Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.
2.

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.

Alton EW, Armstrong DK, Ashby D, Bayfield KJ, Bilton D, Bloomfield EV, Boyd AC, Brand J, Buchan R, Calcedo R, Carvelli P, Chan M, Cheng SH, Collie DD, Cunningham S, Davidson HE, Davies G, Davies JC, Davies LA, Dewar MH, Doherty A, Donovan J, Dwyer NS, Elgmati HI, Featherstone RF, Gavino J, Gea-Sorli S, Geddes DM, Gibson JS, Gill DR, Greening AP, Griesenbach U, Hansell DM, Harman K, Higgins TE, Hodges SL, Hyde SC, Hyndman L, Innes JA, Jacob J, Jones N, Keogh BF, Limberis MP, Lloyd-Evans P, Maclean AW, Manvell MC, McCormick D, McGovern M, McLachlan G, Meng C, Montero MA, Milligan H, Moyce LJ, Murray GD, Nicholson AG, Osadolor T, Parra-Leiton J, Porteous DJ, Pringle IA, Punch EK, Pytel KM, Quittner AL, Rivellini G, Saunders CJ, Scheule RK, Sheard S, Simmonds NJ, Smith K, Smith SN, Soussi N, Soussi S, Spearing EJ, Stevenson BJ, Sumner-Jones SG, Turkkila M, Ureta RP, Waller MD, Wasowicz MY, Wilson JM, Wolstenholme-Hogg P; UK Cystic Fibrosis Gene Therapy Consortium..

Lancet Respir Med. 2015 Sep;3(9):684-91. doi: 10.1016/S2213-2600(15)00245-3. Epub 2015 Jul 3. Erratum in: Lancet Respir Med. 2015 Sep;3(9):e33.

3.

Cystic Fibrosis Gene Therapy in the UK and Elsewhere.

Griesenbach U, Pytel KM, Alton EW.

Hum Gene Ther. 2015 May;26(5):266-75. doi: 10.1089/hum.2015.027. Review.

4.

Gene therapy for the treatment of cystic fibrosis.

Burney TJ, Davies JC.

Appl Clin Genet. 2012 May 29;5:29-36. doi: 10.2147/TACG.S8873. Print 2012.

5.

Advances in cell and gene-based therapies for cystic fibrosis lung disease.

Oakland M, Sinn PL, McCray PB Jr.

Mol Ther. 2012 Jun;20(6):1108-15. doi: 10.1038/mt.2012.32. Epub 2012 Feb 28. Review.

6.

Gene therapy: light is finally in the tunnel.

Cao H, Molday RS, Hu J.

Protein Cell. 2011 Dec;2(12):973-89. doi: 10.1007/s13238-011-1126-y. Epub 2012 Jan 10. Review.

7.

Nanodelivery in airway diseases: challenges and therapeutic applications.

Roy I, Vij N.

Nanomedicine. 2010 Apr;6(2):237-44. doi: 10.1016/j.nano.2009.07.001. Epub 2009 Jul 16. Review.

8.

Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials.

Rowe SM, Accurso F, Clancy JP.

Proc Am Thorac Soc. 2007 Aug 1;4(4):387-98. Review.

9.

Novel molecular approaches to cystic fibrosis gene therapy.

Lee TW, Matthews DA, Blair GE.

Biochem J. 2005 Apr 1;387(Pt 1):1-15. Review.

10.

Gene therapy in clinical medicine.

Selkirk SM.

Postgrad Med J. 2004 Oct;80(948):560-70. Review.

11.

Taking stock of gene therapy for cystic fibrosis.

Stern M, Geddes DM, Alton EW.

Respir Res. 2000;1(2):78-81. Epub 2000 Sep 15. Review.

12.

Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs.

Krieg AM, Wu T, Weeratna R, Efler SM, Love-Homan L, Yang L, Yi AK, Short D, Davis HL.

Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12631-6.

Supplemental Content

Support Center